Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.512 EUR | -0.26% | +0.27% | -41.03% |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | -.--% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.19% | 11.52B | |
+44.16% | 3.27B | |
-19.90% | 2.02B | |
-38.37% | 2.03B | |
-30.21% | 1.44B | |
+16.18% | 1.01B | |
-6.11% | 719M | |
-32.75% | 418M | |
-52.35% | 339M |
- Stock Market
- Equities
- ECX Stock
- ECX Stock
- Company Epigenomics AG